US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ACON

Aclarion (ACON)

Aclarion Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ACON

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/25	22 : 14	GlobeNewswire Inc.	Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain	NASDAQ:ACON	Aclarion Inc
2024/03/07	06 : 09	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ACON	Aclarion Inc
2024/03/04	22 : 00	GlobeNewswire Inc.	Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs	NASDAQ:ACON	Aclarion Inc
2024/02/28	05 : 22	GlobeNewswire Inc.	Aclarion Announces Closing of $3.0 Million Public Offering	NASDAQ:ACON	Aclarion Inc
2024/02/28	04 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACON	Aclarion Inc
2024/02/28	00 : 46	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:ACON	Aclarion Inc
2024/02/27	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ACON	Aclarion Inc
2024/02/26	23 : 15	GlobeNewswire Inc.	Aclarion Announces Pricing of $3.0 Million Public Offering	NASDAQ:ACON	Aclarion Inc
2024/02/24	01 : 46	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:ACON	Aclarion Inc
2024/02/22	07 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACON	Aclarion Inc
2024/02/22	05 : 02	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:ACON	Aclarion Inc
2024/02/07	07 : 32	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:ACON	Aclarion Inc
2024/02/05	22 : 00	GlobeNewswire Inc.	Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership	NASDAQ:ACON	Aclarion Inc
2024/02/02	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ACON	Aclarion Inc
2024/02/02	07 : 16	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ACON	Aclarion Inc
2024/02/01	07 : 26	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:ACON	Aclarion Inc
2024/01/29	20 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACON	Aclarion Inc
2024/01/23	23 : 53	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACON	Aclarion Inc
2024/01/23	06 : 48	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:ACON	Aclarion Inc
2024/01/22	22 : 00	GlobeNewswire Inc.	Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD	NASDAQ:ACON	Aclarion Inc
2024/01/17	22 : 00	GlobeNewswire Inc.	Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution	NASDAQ:ACON	Aclarion Inc
2024/01/13	06 : 15	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ACON	Aclarion Inc
2024/01/08	22 : 00	GlobeNewswire Inc.	Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan	NASDAQ:ACON	Aclarion Inc
2024/01/04	22 : 01	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ACON	Aclarion Inc
2024/01/04	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACON	Aclarion Inc
2024/01/03	02 : 00	GlobeNewswire Inc.	Aclarion Announces Reverse Stock Split	NASDAQ:ACON	Aclarion Inc
2023/12/29	20 : 30	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ACON	Aclarion Inc
2023/12/20	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACON	Aclarion Inc
2023/12/12	06 : 55	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:ACON	Aclarion Inc
2023/11/27	22 : 00	GlobeNewswire Inc.	Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams	NASDAQ:ACON	Aclarion Inc

Showing the most relevant articles for your search:NASDAQ:ACON

1 2 3 4 次へ >>

Feishang Anthracite Reso... (PK)

Timothy Plan High Divide...

Yellow Stem Tech

Transamerica Large Core ...

Cassowary Capital

Vontobel Financial Produ...

Animal Concerts Token

Riedel Resources

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約